Corpus Intelligence IC Memo — HEARTLAND REGIONAL MEDICAL CENTER 2026-04-26 05:27 UTC
IC Memo — HEARTLAND REGIONAL MEDICAL CENTER
Investment Committee Memorandum | IL | 94 beds | Grade C | EBITDA uplift $5.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HEARTLAND REGIONAL MEDICAL CENTER

CCN 140184 | WILLIAMSON, IL | 94 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

HEARTLAND REGIONAL MEDICAL CENTER is a 94-bed suburban community hospital in WILLIAMSON, IL with $67.8M in net patient revenue and a 100.0% operating margin. The hospital serves a payer mix of 43.0% Medicare, 1.9% Medicaid, and 55.1% commercial.

Thesis: Turnaround. Our ML models identify $5.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 100.0% to 142.0% (+736bps).

Net Revenue HCRIS$67.8M
Current EBITDA COMPUTED$91.2M
Operating Margin COMPUTED100.0%
Occupancy HCRIS17.9%
Revenue / Bed COMPUTED$721K
Net-to-Gross HCRIS17.5%
Distress Probability ML55.0%

2. Market Context & Competitive Position

208
IL Hospitals
-5.3%
State Median Margin
78
Comparable Hospitals

IL has 208 Medicare-certified hospitals with a median operating margin of -5.3%. The target's margin of 100.0% places it above the state median. Among 78 size-comparable peers (47-188 beds), the median margin is -8.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (47-188), prioritizing same-state peers. 78 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HEARTLAND REGIONAL MEDICAL CEN (Target)IL94$67.8M100.0%
MIDWESTERN REGIONAL MEDICAL CEIL73$1.38B80.5%
NORTHWESTERN LAKE FOREST HOSPIIL124$494.3M-13.8%
SARAH BUSH LINCOLN HEALTH CENTIL100$448.6M-18.1%
DELNOR-COMMUNITY HOSPITALIL149$441.4M6.4%
GOOD SHEPHERD HOSPITALIL176$375.2M20.0%
SWEDISH COVENANT HEALTHIL173$363.5M-3.8%
MEMORIAL HOSPITAL OF CARBONDALIL175$357.2M14.6%
KISHWAUKEE COMMUNITY HOSPITALIL98$355.3M25.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $5.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.4M+210bp18mo
Cost to Collect4.5%2.5%$1.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$824K+122bp9mo
Clean Claim Rate88.0%96.0%$43K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.4M
Cost to Collect
$1.4M
Denial Rate Reduction
$1.3M
A/R Days Reduction
$824K
Clean Claim Rate
$43K
Total EBITDA Uplift$5.0M
Current EBITDA$91.2M
+ RCM Uplift+$5.0M
Pro Forma EBITDA$96.2M
Current Margin100.0%
Pro Forma Margin142.0%
WC Released (1x)$2.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$140.3M$651.6M4.64x35.9%
Base (11x exit)10.0x11.0x$140.3M$762.4M5.43x40.3%
Bull Case9.0x11.0x$126.3M$824.4M6.53x45.5%
Bull (12x exit)9.0x12.0x$126.3M$936.6M7.42x49.3%
Bear Case11.0x10.0x$154.4M$581.1M3.76x30.4%
Bear (11x exit)11.0x11.0x$154.4M$689.3M4.47x34.9%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 17.9%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 55.0% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 78 hospitals with 47-188 beds
  • Same-state prioritization (n=79)
  • Comp margins: P25=-23.4% / P50=-8.7% / P75=3.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.